Article ID: 92ef3382feaac47914b18f76501dc89fda38adfecb0d7d677dc8ee20f2405af1
Source ID: secondary:businessinsurance.com
Published At: -
Extraction Method: bs4_heuristic
URL: https://www.businessinsurance.com/pennsylvania-hawaii-lawmakers-target-compound-drug-costs/
Body Text
Pennsylvania, Hawaii lawmakers target compound drug costs - Business Insurance Skip to content Register for free Search Search Log In Risk Management Cyber Risks Pricing Trends Mergers & Acquisitions Technology Sponsored Content WSIA RISKWORLD Workers Comp & Safety Workers Comp Cost Control Pain Management Workplace Safety International EMEA Asia-Pacific Latin America People Events BI Intelligence Top 100 Agents & Brokers Best Places to Work 2025 Lists Directories Insurance Pricing BI Stock Index Magazine Current Issue Past Issues Subscribe Women to Watch ALL INsurance Resources Risk Perspectives Sponsored Content Webinars White Papers Risk Management Cyber Risks Pricing Trends Mergers & Acquisitions Technology Sponsored Content WSIA RISKWORLD Workers Comp & Safety Workers Comp Cost Control Pain Management Workplace Safety International EMEA Asia-Pacific Latin America People Events BI Intelligence Top 100 Agents & Brokers Best Places to Work 2025 Lists Directories Insurance Pricing BI Stock Index Magazine Current Issue Past Issues Subscribe Women to Watch ALL INsurance Resources Risk Perspectives Sponsored Content Webinars White Papers Risk Management Cyber Risks Pricing Trends Mergers & Acquisitions Technology Sponsored Content WSIA RISKWORLD Workers Comp & Safety Workers Comp Cost Control Pain Management Workplace Safety International EMEA Asia-Pacific Latin America People Events BI Intelligence Top 100 Agents & Brokers Best Places to Work 2025 Lists Directories Insurance Pricing BI Stock Index Magazine Current Issue Past Issues Subscribe Women to Watch ALL INsurance Resources Risk Perspectives Sponsored Content Webinars White Papers Risk Management Cyber Risks Pricing Trends Mergers & Acquisitions Technology Sponsored Content WSIA RISKWORLD Workers Comp & Safety Workers Comp Cost Control Pain Management Workplace Safety International EMEA Asia-Pacific Latin America People Events BI Intelligence Top 100 Agents & Brokers Best Places to Work 2025 Lists Directories Insurance Pricing BI Stock Index Magazine Current Issue Past Issues Subscribe Women to Watch ALL INsurance Resources Risk Perspectives Sponsored Content Webinars White Papers Pennsylvania, Hawaii lawmakers target compound drug costs by Work Comp Central Workers Comp Cost Control , Workers Comp Coverage , Workers Comp Pricing Mar 17, 2026 Lawmakers in Pennsylvania and Hawaii are proposing legislation that would align state standards with federal laws to crack down on inflated prices for compound drugs in their workers compensation systems. Pennsylvania S.B. 1215, introduced on Friday, and Hawaii H.B. 2164, which was passed to the Senate on March 10, both include references to U.S. Code Section 353. The Hawaii bill would define a compound prescription drug as a medication compounded by a licensed pharmacist in a state-licensed pharmacy for an individual patient, based on a valid prescription. The bill would also require that the drug meet the requirements in Section 353a. The bill’s language is similar to the federal law, which essentially requires compound drugs to be custom-formulated for specific patients. The federal law also includes a provision that prohibits compounding drugs that are essentially copies of a commercially available drug product. The Pennsylvania bill includes a provision that would prohibit reimbursement for a compound drug that duplicates a commercially available product. The bill refers to Section 353b for determining equivalence. Federal law defines an essential copy of an approved drug as a medication that is identical or nearly identical to an already approved drug, unless the approved drug is on the FDA shortage list. The federal law also says a compound is essentially a copy if it uses a bulk drug that is a component of an approved drug, “unless there is a change that produces for an individual patient a clinical difference, as determined by the prescribing practitioner, between the compounded drug and the comparable approved drug.” WorkCompCentral is a sister publication of Business Insurance. More stories here . Related News Berkley broadens lawyer risk management services March 17, 2026 Gulf cargo shifts routes after Hormuz closure March 17, 2026 Panama asks Cosco to reconsider port operations suspension March 17, 2026 SiriusPoint forms London specialty division March 17, 2026 Echo Re to open India branch in GIFT City March 17, 2026 Oman Air Cargo to impose fuel, war risk surcharges March 17, 2026 HDFC Ergo appoints Ghosh as CEO, MD March 17, 2026 India to insure exporters against Red Sea, Hormuz disruptions March 17, 2026 Construction specialist doubles capacity to $85M per project March 17, 2026 Facebook-f X-twitter Linkedin-in Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing. Never miss important news: Become a Business Insurance Online subscriber today Subscribe Now Information About Us Contact Advertise Privacy Policy Terms & Conditions Copyright 2026. BUSINESS INSURANCE HOLDINGS Member, Beacon International Group, Ltd.
Metadata (JSON)
{
"score": 12.583333333333334
}